Qianlan Zhou

No. 36, Sanhao Street
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

SUMO-conjugating enzyme UBE2I inhibition alleviates asthma progression: effects on BHLHE40 and M2 macrophage polarization.

SUMO-conjugating enzyme UBE2I inhibition alleviates asthma progression: effects on BHLHE40 and M2 macrophage polarization.

Journal: International immunopharmacology

Published: November 10, 2025

Response to Letter Regarding Article, "Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma".

Response to Letter Regarding Article, "Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma".

Journal: International forum of allergy & rhinology

Published: June 21, 2025

Parents' knowledge, attitudes and practices towards the prevention and treatment of dust mite allergy: a cross-sectional study in Shenyang (China).

Parents' knowledge, attitudes and practices towards the prevention and treatment of dust mite allergy: a cross-sectional study in Shenyang (China).

Journal: BMJ open

Published: January 14, 2025

BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.

BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.

Journal: Communications biology

Published: August 25, 2024

Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real-life, multi-center study.

Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real-life, multi-center study.

Journal: Allergy

Published: June 11, 2024

Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma.

Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma.

Journal: International forum of allergy & rhinology

Published: May 15, 2024

Safety of subcutaneous immunotherapy with Novo-Helisen-Depot in the children: a retrospective analysis from a single center in Northern China.

Safety of subcutaneous immunotherapy with Novo-Helisen-Depot in the children: a retrospective analysis from a single center in Northern China.

Journal: Frontiers in pediatrics

Published: January 14, 2024

Role of SYVN1 in the control of airway remodeling in asthma protection by promoting SIRT2 ubiquitination and degradation.

Role of SYVN1 in the control of airway remodeling in asthma protection by promoting SIRT2 ubiquitination and degradation.

Journal: Biological research

Published: May 22, 2023

Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis.

Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis.

Journal: Cell cycle (Georgetown, Tex.)

Published: January 03, 2022

Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.

Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.

Journal: Journal of innate immunity

Published: October 24, 2019

MiRNA-451a inhibits airway remodeling by targeting Cadherin 11 in an allergic asthma model of neonatal mice.

MiRNA-451a inhibits airway remodeling by targeting Cadherin 11 in an allergic asthma model of neonatal mice.

Journal: International immunopharmacology

Published: October 09, 2019

Protective effects of a neurokinin 1 receptor antagonist on airway epithelial mitochondria dysfunction in asthmatic mice via Nrf2/HO-1 activation.

Protective effects of a neurokinin 1 receptor antagonist on airway epithelial mitochondria dysfunction in asthmatic mice via Nrf2/HO-1 activation.

Journal: International immunopharmacology

Published: August 04, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026